TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Use of Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery
Brief Summary: The investigators prepared a novel study of tranexamic acid (TXA) designed to estimate the quantity of blood loss in women undergoing elective repeat cesarean deliveries. This is the first trial to utilize a prophylactic dose of TXA prior to incision followed by a subsequent prophylactic dose at placental delivery in obstetric patients undergoing scheduled cesareans. The purpose of this study is to quantify blood loss during uncomplicated repeat cesarean deliveries with and without TXA. The central hypothesis is that TXA administration reduces blood loss and fibrinolysis in women undergoing repeat cesarean sections.


Options:
A: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic acid | Arm Label: 2; Type: PLACEBO_COMPARATOR; Interventions: Drug: Sodium Chloride 0.9% | Intervention Type: DRUG; Name: Tranexamic acid; Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Sodium Chloride 0.9%; Assigned to Arm(s): 2
B: Arm Label: Intravenous tranexamic acid; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid 100Mg/Ml Inj Vil 10Ml | Arm Label: Intramuscular tranexamic acid; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid Injectable Product | Arm Label: Oral liquid tranexamic acid; Type: EXPERIMENTAL; Interventions: Drug: Tranexamic Acid Oral Solution | Arm Label: No tranexamic acid; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Tranexamic Acid 100Mg/Ml Inj Vil 10Ml; Assigned to Arm(s): Intravenous tranexamic acid | Intervention Type: DRUG; Name: Tranexamic Acid Oral Solution; Assigned to Arm(s): Oral liquid tranexamic acid | Intervention Type: DRUG; Name: Tranexamic Acid Injectable Product; Assigned to Arm(s): Intramuscular tranexamic acid
C: Arm Label: Tranexamic acid group; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic Acid, Procedure: Cesarean section | Arm Label: Control group; Type: PLACEBO_COMPARATOR; Interventions: Procedure: Cesarean section | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Tranexamic acid group | Intervention Type: PROCEDURE; Name: Cesarean section; Assigned to Arm(s): Control group, Tranexamic acid group
D: Arm Label: Tranexamic acid; Type: ACTIVE_COMPARATOR; Interventions: Drug: Tranexamic Acid | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Tranexamic Acid; Assigned to Arm(s): Tranexamic acid | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prophylatic Effect of Preoperative Antibiotics With Mechanical Bowel Preparation Compare With Simple Mechanical Bowel Preparation Before Laparoscopic Colorectal Surgery: a Randomized Controlled Trial
Brief Summary: Surgical site infection (SSI) is a major postoperative complication after abdominal surgery especially in colorectal field, which significantly increases length of stay (LOS), readmission incidence and expense. Therefore, identification of the effective method to reduce SSI incidence is critically important. Combination of oral antibiotics and mechanical bowel preparation was reported with lower SSIs and LOS in some retrospecitve data analysis, however a prospective randmized controlled trial was absent. Herein, the current randomized controlled trial comparing MBP+OA with MBP alone in postoperative complications in order to guide clinical practise was conducted.


Options:
A: Arm Label: Group A: IV and Oral antibiotics (IVA+OA); Type: ACTIVE_COMPARATOR; Interventions: Other: IVA+OA versus IVA+MBP+OA | Arm Label: Group B: IV antibiotics, MBP and oral antibiotics (IVA+MBP+OA); Type: ACTIVE_COMPARATOR; Interventions: Other: IVA+OA versus IVA+MBP+OA | Intervention Type: OTHER; Name: IVA+OA versus IVA+MBP+OA; Assigned to Arm(s): Group A: IV and Oral antibiotics (IVA+OA), Group B: IV antibiotics, MBP and oral antibiotics (IVA+MBP+OA)
B: Arm Label: oral antibiotics+mechanical bowel preparation; Type: EXPERIMENTAL; Interventions: Drug: Neomycin,metronidazole | Arm Label: simple mechanical bowel preparation; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Neomycin,metronidazole; Assigned to Arm(s): oral antibiotics+mechanical bowel preparation
C: Arm Label: Mechanical Bowel Preparation and Oral Antibiotics; Type: EXPERIMENTAL; Interventions: Drug: Oral Antibiotics, Drug: Mechanical Bowel Preparation | Arm Label: Mechanical Bowel Preparation Only; Type: ACTIVE_COMPARATOR; Interventions: Drug: Placebo, Drug: Mechanical Bowel Preparation | Intervention Type: DRUG; Name: Oral Antibiotics; Assigned to Arm(s): Mechanical Bowel Preparation and Oral Antibiotics | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Mechanical Bowel Preparation Only | Intervention Type: DRUG; Name: Mechanical Bowel Preparation; Assigned to Arm(s): Mechanical Bowel Preparation Only, Mechanical Bowel Preparation and Oral Antibiotics
D: Arm Label: Standard treatment; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Selective decontamination of the digestive tract (SDD); Type: EXPERIMENTAL; Interventions: Drug: Selective decontamination of the digestive tract (SDD) (colistin sulfate, tobramycin, amphotericin B) | Intervention Type: DRUG; Name: Selective decontamination of the digestive tract (SDD) (colistin sulfate, tobramycin, amphotericin B); Assigned to Arm(s): Selective decontamination of the digestive tract (SDD)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomized, Controlled Trial to Evaluate the Safety and Effectiveness of the TearCare® System in the Treatment of the Signs and Symptoms of Dry Eye Disease
Brief Summary: In this study, the TearCare System will be compared with the LipiFlow Thermal Pulsation System in patients with dry eye disease. The objective is to demonstrate that the TearCare System is safe and effective in relieving the signs and symptoms of dry eye disease.

NOTE: All sites have been selected for this study. We are not seeking additional sites at this time.


Options:
A: Arm Label: Standard Lid Hygiene Regime; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Lid hygiene regime | Arm Label: Lipiflow; Type: ACTIVE_COMPARATOR; Interventions: Device: Lipiflow | Intervention Type: DEVICE; Name: Lipiflow; Assigned to Arm(s): Lipiflow | Intervention Type: BEHAVIORAL; Name: Lid hygiene regime; Assigned to Arm(s): Standard Lid Hygiene Regime
B: Arm Label: LipiFlow group; Type: EXPERIMENTAL; Interventions: Device: LipiFlow Thermal pulsation system | Arm Label: Control group; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Eyelid warm compresses plus massages | Intervention Type: DEVICE; Name: LipiFlow Thermal pulsation system; Assigned to Arm(s): LipiFlow group | Intervention Type: PROCEDURE; Name: Eyelid warm compresses plus massages; Assigned to Arm(s): Control group
C: Arm Label: TearCare; Type: EXPERIMENTAL; Interventions: Device: TearCare | Arm Label: LipiFlow; Type: ACTIVE_COMPARATOR; Interventions: Device: LipiFlow | Intervention Type: DEVICE; Name: TearCare; Assigned to Arm(s): TearCare | Intervention Type: DEVICE; Name: LipiFlow; Assigned to Arm(s): LipiFlow
D: Arm Label: Treatment; Type: EXPERIMENTAL; Interventions: Procedure: Thermal Pulsation therapy | Intervention Type: PROCEDURE; Name: Thermal Pulsation therapy; Assigned to Arm(s): Treatment

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Spinal Cord Stimulation System in the Treatment of Chronic Pain
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of spinal cord stimulation (SCS) using the PINS spinal cord stimulator device for chronic and intractable pain.


Options:
A: Arm Label: Burst spinal cord stimulation (SCS); Type: EXPERIMENTAL; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Arm Label: sham spinal cord stimulation (SCS); Type: SHAM_COMPARATOR; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Intervention Type: PROCEDURE; Name: Burst Spinal Cord Stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS) | Intervention Type: PROCEDURE; Name: Sham spinal cord stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS)
B: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Device: PINS Spinal Cord Stimulator | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Device: PINS Spinal Cord Stimulator | Intervention Type: DEVICE; Name: PINS Spinal Cord Stimulator; Assigned to Arm(s): Control, Experimental
C: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: placebo | Arm Label: Pregabalin 300 mg/day; Type: EXPERIMENTAL; Interventions: Drug: pregabalin | Arm Label: Pregabalin 600 mg/day; Type: EXPERIMENTAL; Interventions: Drug: pregabalin | Intervention Type: DRUG; Name: placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): Pregabalin 300 mg/day | Intervention Type: DRUG; Name: pregabalin; Assigned to Arm(s): Pregabalin 600 mg/day
D: Arm Label: EES on; Type: EXPERIMENTAL; Interventions: Device: EES on | Arm Label: EES off; Type: PLACEBO_COMPARATOR; Interventions: Device: EES off | Intervention Type: DEVICE; Name: EES on; Assigned to Arm(s): EES on | Intervention Type: DEVICE; Name: EES off; Assigned to Arm(s): EES off

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Spinal Cord Stimulation System in the Treatment of Chronic Pain
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of spinal cord stimulation (SCS) using the PINS spinal cord stimulator device for chronic and intractable pain.


Options:
A: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Device: PINS Spinal Cord Stimulator | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Device: PINS Spinal Cord Stimulator | Intervention Type: DEVICE; Name: PINS Spinal Cord Stimulator; Assigned to Arm(s): Control, Experimental
B: Arm Label: Sham; Type: SHAM_COMPARATOR; Interventions: Device: Sham | Arm Label: 1200 Hz; Type: EXPERIMENTAL; Interventions: Device: 1200 Hz | Arm Label: 3030 Hz; Type: EXPERIMENTAL; Interventions: Device: 3030 Hz | Arm Label: 5882 Hz; Type: EXPERIMENTAL; Interventions: Device: 5882 Hz | Intervention Type: DEVICE; Name: Sham; Assigned to Arm(s): Sham | Intervention Type: DEVICE; Name: 1200 Hz; Assigned to Arm(s): 1200 Hz | Intervention Type: DEVICE; Name: 3030 Hz; Assigned to Arm(s): 3030 Hz | Intervention Type: DEVICE; Name: 5882 Hz; Assigned to Arm(s): 5882 Hz
C: Intervention Type: DEVICE; Name: Spinal Cord Stimulation; Assigned to Arm(s): N/A
D: Arm Label: Sequence 1; Type: OTHER; Interventions: Device: High frequency spinal cord stimulation | Arm Label: Sequence 2; Type: OTHER; Interventions: Device: High frequency spinal cord stimulation | Intervention Type: DEVICE; Name: High frequency spinal cord stimulation; Assigned to Arm(s): Sequence 1, Sequence 2

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Spinal Cord Stimulation System in the Treatment of Chronic Pain
Brief Summary: The purpose of this study is to evaluate the efficacy and safety of spinal cord stimulation (SCS) using the PINS spinal cord stimulator device for chronic and intractable pain.


Options:
A: Intervention Type: DEVICE; Name: Medtronic Manufactured Spinal Cord Stimulators; Assigned to Arm(s): N/A
B: Arm Label: Burst spinal cord stimulation (SCS); Type: EXPERIMENTAL; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Arm Label: sham spinal cord stimulation (SCS); Type: SHAM_COMPARATOR; Interventions: Procedure: Burst Spinal Cord Stimulation, Procedure: Sham spinal cord stimulation | Intervention Type: PROCEDURE; Name: Burst Spinal Cord Stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS) | Intervention Type: PROCEDURE; Name: Sham spinal cord stimulation; Assigned to Arm(s): Burst spinal cord stimulation (SCS), sham spinal cord stimulation (SCS)
C: Arm Label: Monocolumn spinal cord stimulation; Type: ACTIVE_COMPARATOR; Interventions: Device: comparison of spinal cord stimulation | Arm Label: Multicolumn spinal cord stimulation; Type: EXPERIMENTAL; Interventions: Device: comparison of spinal cord stimulation | Intervention Type: DEVICE; Name: comparison of spinal cord stimulation; Assigned to Arm(s): Monocolumn spinal cord stimulation, Multicolumn spinal cord stimulation
D: Arm Label: Experimental; Type: EXPERIMENTAL; Interventions: Device: PINS Spinal Cord Stimulator | Arm Label: Control; Type: SHAM_COMPARATOR; Interventions: Device: PINS Spinal Cord Stimulator | Intervention Type: DEVICE; Name: PINS Spinal Cord Stimulator; Assigned to Arm(s): Control, Experimental

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Validation of a Midwifery Model in Palestine
Brief Summary: This study investigate if a midwife-led continuity model of care in Palestine, had impact on rural women's satisfaction with care through the continuum of antenatal, intrapartum and postnatal period.


Options:
A: Arm Label: Arm 1: Routine Care; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Arm 2:Behavioral Intervention with nudges & Facebook; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Arm 2:Behavioral Intervention with nudges & Facebook interaction | Arm Label: Arm 3: Community Intervention with individualised teleconferencing sessions and phone calls.; Type: ACTIVE_COMPARATOR; Interventions: Other: Arm 3: Community Intervention with individualised teleconferencing sessions and phone calls. | Intervention Type: BEHAVIORAL; Name: Arm 2:Behavioral Intervention with nudges & Facebook interaction; Assigned to Arm(s): Arm 2:Behavioral Intervention with nudges & Facebook | Intervention Type: OTHER; Name: Arm 3: Community Intervention with individualised teleconferencing sessions and phone calls.; Assigned to Arm(s): Arm 3: Community Intervention with individualised teleconferencing sessions and phone calls.
B: Arm Label: Midwife-led continuity of care; Type: N/A; Interventions: Behavioral: Midwife-led continuity of care | Arm Label: Regular care; Type: N/A; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Midwife-led continuity of care; Assigned to Arm(s): Midwife-led continuity of care
C: Arm Label: ChroPreg; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: ChroPreg + standard care | Arm Label: Standard care alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: ChroPreg + standard care; Assigned to Arm(s): ChroPreg
D: Arm Label: Continuity of midwifery care; Type: OTHER; Interventions: Procedure: Continuity of midwifery care | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: PROCEDURE; Name: Continuity of midwifery care; Assigned to Arm(s): Continuity of midwifery care

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prevention of Hypertensive Injury to the Brain by Intensive Treatment of Blood Pressure After Intracerebral Haemorrhage
Brief Summary: PROHIBIT-ICH will randomise participants (target=112) to compare a strategy of intensive blood pressure (BP) treatment (target \<120/80 mm Hg) guided by remote telemetric home BP monitoring, versus standard primary care, in adult survivors of small vessel disease-related ICH. The investigators will establish the feasibility and safety of the intervention, the efficacy of BP reduction, and explore whether it reduces the progression of SVD-related injury on brain MRI.


Options:
A: Arm Label: Telemetric Bluetooth-enabled home BP monitors; Type: EXPERIMENTAL; Interventions: Device: A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci | Arm Label: Standard clinical care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: A&D BP Digital Blood Pressure Monitor (UA-767PBT-Ci) CE Declaration UA-767PBT-Ci; Assigned to Arm(s): Telemetric Bluetooth-enabled home BP monitors
B: Arm Label: Direct Oral Anticoagulant (DOAC); Type: EXPERIMENTAL; Interventions: Drug: Apixaban 5 MG | Arm Label: Left Atrial Appendage Closure (LAAC); Type: EXPERIMENTAL; Interventions: Device: left atrial appendage closure | Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Apixaban 5 MG; Assigned to Arm(s): Direct Oral Anticoagulant (DOAC) | Intervention Type: DEVICE; Name: left atrial appendage closure; Assigned to Arm(s): Left Atrial Appendage Closure (LAAC)
C: Arm Label: Start oral anticoagulant (OAC); Type: EXPERIMENTAL; Interventions: Drug: Apixaban, Drug: Rivaroxaban, Drug: Edoxaban, Drug: Dabigatran, Drug: Acenocoumarol, Drug: Phenindione, Drug: Warfarin | Arm Label: Do not start oral anticoagulant (OAC); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DRUG; Name: Apixaban; Assigned to Arm(s): Start oral anticoagulant (OAC) | Intervention Type: DRUG; Name: Rivaroxaban; Assigned to Arm(s): Start oral anticoagulant (OAC) | Intervention Type: DRUG; Name: Edoxaban; Assigned to Arm(s): Start oral anticoagulant (OAC) | Intervention Type: DRUG; Name: Dabigatran; Assigned to Arm(s): Start oral anticoagulant (OAC) | Intervention Type: DRUG; Name: Acenocoumarol; Assigned to Arm(s): Start oral anticoagulant (OAC) | Intervention Type: DRUG; Name: Phenindione; Assigned to Arm(s): Start oral anticoagulant (OAC) | Intervention Type: DRUG; Name: Warfarin; Assigned to Arm(s): Start oral anticoagulant (OAC)
D: Arm Label: Study I (AF); Type: N/A; Interventions: N/A | Arm Label: Study II (ICH); Type: N/A; Interventions: N/A

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Carbetocin Versus Oxytocin Plus Sublingual Misoprostol in the Management of Atonic Post-partum Hemorrhage (PPH) After Vaginal Delivery: a Randomized Controlled Trial
Brief Summary: The objective of this study is to compare the effectiveness and safety of carbetocin vs. oxytocin plus sublingual misoprostol in the management of atonic postpartum hemorrhage (PPH)after vaginal delivery.


Options:
A: Arm Label: Carbetocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Arm Label: Oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Oxytocin | Intervention Type: DRUG; Name: Carbetocin; Assigned to Arm(s): Carbetocin | Intervention Type: DRUG; Name: Oxytocin; Assigned to Arm(s): Oxytocin
B: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: MISOPROSTOL; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): MISOPROSTOL | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
C: Arm Label: Misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Misoprostol, Placebo
D: Arm Label: oxytocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: oxytocin | Arm Label: oxytocin plus misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: oxytocin, Drug: oxytocin plus misoprostol | Arm Label: Carbetocin; Type: ACTIVE_COMPARATOR; Interventions: Drug: Carbetocin | Intervention Type: DRUG; Name: oxytocin; Assigned to Arm(s): oxytocin, oxytocin plus misoprostol | Intervention Type: DRUG; Name: oxytocin plus misoprostol; Assigned to Arm(s): oxytocin plus misoprostol | Intervention Type: DRUG; Name: Carbetocin; Assigned to Arm(s): Carbetocin

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: The Use of Prophylactic Negative Wound Therapy in Emergency and Elective Laparotomy Wounds
Brief Summary: Post-operative wound issues in abdominal surgery have a significant impact on patient outcomes. The impact of different types of wound therapy are not clear in the literature.

The hypothesis of this study is that NPWT has the potential to reduce Surgical Site Infections, however no study has compared the most commonly used products against standard dressings.


Options:
A: Arm Label: Simple dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Smith & Nephew PICO Negative wound pressure versus standard dresing, Device: PREVENA Negative pressure wound versus standard dressing | Arm Label: PICO Dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: PREVENA Negative pressure wound versus standard dressing | Arm Label: PREVENA Dressing; Type: ACTIVE_COMPARATOR; Interventions: Device: Smith & Nephew PICO Negative wound pressure versus standard dresing | Intervention Type: DEVICE; Name: Smith & Nephew PICO Negative wound pressure versus standard dresing; Assigned to Arm(s): PREVENA Dressing, Simple dressing | Intervention Type: DEVICE; Name: PREVENA Negative pressure wound versus standard dressing; Assigned to Arm(s): PICO Dressing, Simple dressing
B: Arm Label: Current Standard; Type: ACTIVE_COMPARATOR; Interventions: Device: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing | Arm Label: Negative Pressure Wound Therapy; Type: EXPERIMENTAL; Interventions: Device: Prevena (Negative Pressure Wound Therapy Device) | Intervention Type: DEVICE; Name: Prevena (Negative Pressure Wound Therapy Device); Assigned to Arm(s): Negative Pressure Wound Therapy | Intervention Type: DEVICE; Name: Standard Tegaderm (3M Healthcare, St. Paul, MN) adhesive dressing; Assigned to Arm(s): Current Standard
C: Arm Label: Prevena device (Group A); Type: EXPERIMENTAL; Interventions: Device: Prevena device (Group A) | Arm Label: Conventional dressing (Group B); Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: DEVICE; Name: Prevena device (Group A); Assigned to Arm(s): Prevena device (Group A)
D: Arm Label: patients with preventive PICO; Type: ACTIVE_COMPARATOR; Interventions: Device: PICO DRESSING | Arm Label: patients with preventive MEPORE; Type: PLACEBO_COMPARATOR; Interventions: Device: MEPORE dressing | Intervention Type: DEVICE; Name: PICO DRESSING; Assigned to Arm(s): patients with preventive PICO | Intervention Type: DEVICE; Name: MEPORE dressing; Assigned to Arm(s): patients with preventive MEPORE

Answer: A